Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Optimizing care for rheumatic patients around surgery: Perioperative Management of Rheumatic Disease.
Perioperative Management of Rheumatic Disease" refers to the comprehensive care provided to individuals with rheumatic conditions before, during, and after surgery. Rheumatic diseases, such as rheumatoid arthritis, lupus, and ankylosing spondylitis, pose unique challenges in the perioperative period due to their impact on the musculoskeletal and immune systems.
The goal of perioperative management is to optimize patient outcomes by addressing disease activity, medication management, and surgical considerations. This involves careful preoperative assessment to identify and mitigate potential risks, coordination with rheumatologists and other specialists, and tailored anesthesia and postoperative care strategies.
Additionally, the use of disease-modifying medications, such as DMARDs and biologics, may require adjustment to minimize perioperative complications and optimize healing. A multidisciplinary approach involving rheumatologists, surgeons, anesthesiologists, and other healthcare professionals is essential to ensure the safe and successful perioperative management of patients with rheumatic disease.
Therefore, get an overall knowledge on Optimizing care for rheumatic patients around surgery: Perioperative Management of Rheumatic Disease. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessi
See More Webinars @ Hidoc Webinars
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
3.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
4.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
5.
A promising medication could slow brain tumors in children.
1.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
2.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
3.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Generative AI for Adaptive Oncology Trial Design
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation